Sponsor: Center for International Blood and Marrow Transplant Research
Sponsor Study ID: ACCESS
Study Title: ACCESS: A Multi Center, Phase II Trial of HLA Mismatched Unrelated Donor Hematopoietic Cell Transplantation with Post Transplantation Cyclophosphamide for Patients with Hematologic Malignancies.
CTO #: 103423
NCT Number: NCT04904588
Phase: II
Protocol Type: Treatment
Age Group: Adults
Disease Sites: Lymphoid Leukemia, Myeloid and Monocytic Leukemia, Non-Hodgkin's Lymphoma
Study Objectives: To determine overall survival (OS) at one year following transplantation of a PBSC product from a MMUD using PTCy based GVHD prophylaxis